CD1A and lung adenocarcinoma: Given the fact that CD1A immunohistochemistry is already performed routinely in many institutes of pathology in order to detect CD1A expressing Langerhans cells, implementation of CD1A staining in routine diagnostics for resected early-stage lung adenocarcinoma is easily feasible.